Skip to content

EDX Medical Group - Investor Evening


Announcement provided by

EDX Medical Group Plc · EDX

12/07/2024 11:24

EDX Medical Group - Investor Evening
RNS Number : 2510W
EDX Medical Group PLC
12 July 2024
 

A blue hexagon with white x and blue x Description automatically generated with low confidence

 

12 July 2024

 

EDX Medical Group plc

 

AQSE: EDX

("EDX Medical" or the "Company")

 

Investor Evening

 

CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, is pleased to announce its participation in "The Pub Test" Investor Evening. This event is co-hosted by the Aquis Exchange and InvestorHub and will take place on Wednesday, 17th July 2024 at Samuel Pepys, Stew Ln, London EC4V 3PT, starting at 6:00 PM.

 

The Company's CEO, Dr Mike Hudson, will engage in a conversation designed especially for private investors. This informal setting offers an opportunity for attendees to interact directly with company executives, ask questions, and network with fellow investors.

 

Commenting on the event, Dr Mike Hudson, said:

"We look forward to meeting and engaging with interested parties, shareholders, potential shareholders, and stakeholders, share our vision and answer any questions investors may have."

 

All attendees will have the chance to network over drinks and a buffet.

 

To register for the event, please use the following link: https://events.humanitix.com/the-pub-test-or-london-july-4-2024

 

ENDS

 

Contacts:

EDX Medical plc

Dr Mike Hudson (Chief Executive Officer)

+44 (0)7812 345 301

Oberon Capital

Nick Lovering (Corporate Adviser)

Adam Pollock (Corporate Broking)

Mike Seabrook (Corporate Broking)

+44 (0)20 3179 5300

Media House International

Ramsay Smith

 


Gary McQueen

 

+44 (0)7788 414856

ramsay@mediahouse.co.uk 


+ 44 (0)7834 694609

gary@mediahouse.co.uk

IFC Advisory (Investor Relations)

Tim Metcalfe

Graham Herring

+44 (0) 203 934 6630

 

 

About EDX Medical Group

 

The EDX Medical Group plc is listed on the Apex Segment of the AQSE Growth Market (TIDM: EDX).

 

EDX Medical was founded by Professor Sir Christopher Evans, OBE, a medical and life sciences entrepreneur with more than 30 years of experience, together with CEO, Dr Mike Hudson.

 

By translating clinical insights into pragmatic solutions combining advanced biological and digital technologies, EDX Medical seeks to cost effectively improve the detection and characterisation of disease in order to personalise treatment in a timely fashion. Early disease detection and biologically-based personal treatment optimisation is considered to be the most impactful way of reducing deaths and lowering the cost of healthcare globally.

 

EDX Medical Group provides doctors, hospitals and insurers/payers with access to a portfolio of the best clinical diagnostics products and services. The Company operates its own facilities in Cambridge and Oxford, UK, and has strategic product and technology partnerships with organisations such as Thermo Fisher EMEA Ltd, a world leader in supplying life sciences solutions and services.

 

EDX Medical conducts product development, validation and distribution to ISO 13485 and provides PCR and genomic sequencing services accredited to ISO 15189 by the United Kingdom Accreditation Service (UKAS).

 

www.edxmedical.com

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASFDFSEELSEEW]]>

View more ...

EDX announcementsAll announcements

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers
ISO 27001 Certified

© Aquis Exchange 2024. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal